Table 2.
Absolute frequency (n) and proportion (%) of comorbidities in patients with controlled severe asthma (CSA) and uncontrolled severe asthma (UCSA).
| Total | CSA | UCSA | ||
|---|---|---|---|---|
| Comorbidities | n (%) | n (%) | n (%) | P |
| Diabetes | 8 (13.0) | 0 (0.0) | 8 (13.0) | 0.001 |
| HBP | 12 (20) | 3 (5.0) | 9 (15.0) | 0.110 |
| Rhinitis | 35 (58.3) | 22 (36.6) | 13 (21.6) | 0.001 |
| Rhinosinusitis | 5 (8.3) | 2 (2.2) | 3 (5.0) | 0.814 |
| GERD | 19 (31.6) | 10 (16.6) | 9 (15.0) | 0.420 |
| Obesity | 31 (51.6) | 11 (18.3) | 20 (33.0) | 0.124 |
| AD | 9 (15.0) | 6 (10.0) | 3 (5.0) | 0.156 |
| AERD | 6 (10.0) | 0 (0.0) | 6 (10.0) | 0.005 |
UCSA was defined by the presence of at least one exacerbation in the year; HBP, high blood pressure; GERD, gastroesophageal reflux disease; AD, atopic dermatitis; AERD, aspirin-exacerbated respiratory disease; P, p-value resulting from the Chi-squared test